Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment

MLA

Christine Desenclos, et al. Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment. Jan. 2017. EBSCOhost, https://doi.org/10.7150/jca.18339⟩.

APA

Christine Desenclos, M C Morisse, Taillandier L, S. Trudel, Le Rhun E, Roufai Db, Blanchard N, Bruno Chauffert, Coutte A, Mathieu Boone, Faivre Jc, Blonski M, & I. Darmon. (2017). Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment. https://doi.org/10.7150/jca.18339⟩

Chicago

Christine Desenclos, M C Morisse, Taillandier L, S. Trudel, Le Rhun E, Roufai Db, Blanchard N, et al. 2017. “Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment,” January. doi:10.7150/jca.18339⟩.